1. Kimura, Y., Taniguchi, M., & Baba, K. (2002). Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer research, 22(6A), 3309-3318.
2. Min, B.-S., Nakamura, N., Miyashiro, H., Bae, K.-W. & Hattori, M. (1998). Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chemical and Pharmaceutical Bulletin, 46: 1607-1612.
3. Khoda, H., Tokumoto, W., Sakamoto, K., Fujii, M., Hirai, Y., Tamasaki, K., Komoda, Y., Nakamure, H., Ishihara, S. & Uchida, M. (1985). The biologically active constituents of Ganoderma lucidum (Fr.) Karst. histamine release-inhibitory triterpenes. Chemical and Pharmaceutical Bulletin, 33: 1367-1374
4. Shi, Y., Sun, J., He, H., Guo, H., & Zhang, S. (2008). Hepatoprotective effects of Ganoderma lucidum peptides against D-galactosamine-induced liver injury in mice. Journal of Ethnopharmacology, 117(3), 415-419.
5. Jin, X., Ruiz Beguerie, J., Sze, D. M. Y., & Chan, G. C. (2012). Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev, 6.
6. Lee, S. S., Lee, P. L., Chen, C. F., Wang, S. Y., & Chen, K. Y. (2003). Antitumor effects of polysaccharides of Ganoderma lucidum (Curt.: Fr.) P. Karst.(Ling Zhi, Reishi mushroom)(Aphyllophoromycetideae). International Journal of Medicinal Mushrooms, 5(1).